Neoadjuvant Chemotherapy Prior to Trimodality Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
Keiichiro Miyajima(Jikei University School of Medicine), Shahrokh F. Shariat(Cornell University), Navid Roessler(Universität Hamburg), Fumihiko Urabe(Jikei University School of Medicine), Ahmed R Alfarhan(Comprehensive Cancer Center Vienna), Keiichiro Mori(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Marcin Miszczyk(Comprehensive Cancer Center Vienna), Shota Inoue(Okayama University), Abdulrahman Alqahtani(Prince Sattam Bin Abdulaziz University), Takahiro Kimura(Jikei University School of Medicine), Pierre I. Karakiewicz(Université de Montréal), Akihiro Matsukawa(Jikei University School of Medicine)
Cited by 1
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
|European Urology|2012|257
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy
|European Journal of Cancer|2013|170